Does vitamin D deficiency lead to muscle weakness via vitamin D receptor signaling?

Based on a rigorous review of epidemiological, genetic, and mechanistic evidence, the claim that vitamin D deficiency is associated with muscle weakness and that vitamin D receptor (VDR) signaling directly influences skeletal muscle performance is supported by science.

Below is a detailed synthesis of the evidence mapping the clinical and cellular connections between vitamin D and muscle function.

Clinical evidence and associations

• Epidemiological and genetic links: Observational studies and Mendelian randomization analyses establish a robust association between vitamin D deficiency (serum 25-hydroxyvitamin D [25(OH)D] < 20 ng/mL) and clinical muscle weakness, lower handgrip strength, and sarcopenia. Genetically instrumented increases in 25(OH)D are associated with higher muscle mass and significantly reduced odds of sarcopenia.
• Clinical interventions: Correcting severe vitamin D deficiency in frail, elderly, or post-surgical cohorts modestly improves functional performance and muscle strength. However, in healthy, vitamin D-replete adults or athletic populations, isolated vitamin D supplementation does not provide additional ergogenic or strength benefits.
• Synergistic effects: Therapeutic benefits are maximized when vitamin D correction is combined with structured physical exercise or resistance training, rather than administered as a monotherapy.

Mechanistic pathways of VDR signaling

• Intracellular calcium homeostasis: VDR signaling plays a direct role in regulating intracellular calcium handling within myocytes. This rapid, non-genomic pathway is essential for sarcoplasmic reticulum function and excitation-contraction coupling, which drives muscle fiber contraction.
• Mitochondrial function and energy metabolism: Preclinical models demonstrate that VDR knockdown in adult skeletal muscle directly impairs mitochondrial respiratory capacity and downregulates key mitochondrial gene sets, leading to metabolic myopathy.
• Muscle fiber preservation: Genomic VDR signaling governs transcription programs linked to myogenic differentiation, protein synthesis, and muscle fiber cross-sectional area. In vivo, the loss or deletion of VDR leads to muscle fiber atrophy, increased catabolic autophagy, and a sarcopenia-like functional decline, independent of systemic calcium levels.

Bottom line

Vitamin D deficiency is a major risk factor for muscle weakness and sarcopenia. This relationship is biologically mediated by the vitamin D receptor (VDR), which directly regulates intracellular calcium handling, mitochondrial respiration, and protein synthesis within skeletal muscle tissue. For individuals with low vitamin D levels, correcting the deficiency—ideally paired with resistance exercise—is an effective, evidence-based strategy to support and restore skeletal muscle performance.